Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 744 All time
- Disclosed funding
- $25.4B 609 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| GG Greater Good HealthCompany profile Provides value-based primary care through nurse practitioner-centric model Provides value-based primary care through nurse practitioner-centric model | $20.5M | Series B | Healthtech | United States | Investors | |
| TH Provides virtual-first healthcare across the GCC | $15M | Pre-Series BUndisclosed | Healthtech | United Arab Emirates | Investors | |
| N NexCureCompany profile Provides CAR-T and other advanced treatment delivery in community outpatient settings Provides CAR-T and other advanced treatment delivery in community outpatient settings | $19M | Series A | Healthtech | United States | Investors | |
| S Provides AI-powered care platform for senior living and skilled nursing | $65M | Series CSeries C+ | Healthtech | United States | Investors | |
| A AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $9M | BioMaP project agreement expansionUndisclosed | Healthtech, Biotech | United States | Investors Undisclosed | |
| ES Provides AI-powered health sensing system for sleep and recovery | $50M | StrategicUndisclosed | Healthtech | United States | Investors | |
| XS Xsensio SACompany profile Develops wearable biosensing platform for continuous biochemical monitoring Develops wearable biosensing platform for continuous biochemical monitoring | $7M | Series A | Healthtech | Switzerland | Investors | |
| GT Grow TherapyCompany profile Supports providers delivering in-person and online therapy and psychiatric care. Supports providers delivering in-person and online therapy and psychiatric care. | $150M | Series DSeries C+ | Healthtech | United States | Investors | |
| PT Poplar TherapeuticsCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $45M | Series A+Series A | Healthtech, Biotech | United States | Investors | |
| PM Polares MedicalCompany profile Develops the MRace Posterior Leaflet Replacement system, a transcatheter therapy for mitral regurgitation Develops the MRace Posterior Leaflet Replacement system, a transcatheter therapy for mitral regurgitation | $50M | Series CSeries C+ | Healthtech | Switzerland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →